Compounds > adenosine monophosphate
Page last updated: 2024-08-17

adenosine monophosphate and salmeterol xinafoate

adenosine monophosphate has been researched along with salmeterol xinafoate in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (35.71)18.2507
2000's7 (50.00)29.6817
2010's2 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bolliger, CT; Elsasser, S; Joos, L; Perruchoud, AP; Solèr, M1
Douma, RR; Koëter, GH; Postma, DS; Weersink, EJ1
Barnes, PJ; Worsdell, M; Yates, DH1
Aikman, SL; Barnes, PJ; Harris, JG; Jensen, MW; O'Connor, BJ; Taylor, DA1
Cockcroft, DW1
Dempsey, OJ; Lipworth, BJ; Mistry, C; Sims, EJ; Wilson, AM1
Dempsey, OJ; Lipworth, BJ; Sims, EJ; Wilson, AM1
Gutiérrez, V; Marín, J; Prieto, L; Torres, V; Uixera, S1
Bates, CE; Currie, GP; Haggart, K; Lee, DK; Lipworth, BJ1
Bates, CE; Currie, GP; Jackson, CM; Lee, DK; Lipworth, BJ1
Fang, X; Frank, JA; Matthay, MA; McAuley, DF1
Fardon, TC; Hodge, MR; Lee, DK; Lipworth, BJ1
Burns, P; Lipworth, BJ; Nair, A; Short, P1
Austin, RP; Bonnert, R; Cadogan, E; Connolly, S; Gardiner, P; Jordan, S; Lawson, M; Nicholls, DJ; Paine, SW; Young, A1

Reviews

1 review(s) available for adenosine monophosphate and salmeterol xinafoate

ArticleYear
Inhaled beta2-agonists and airway responses to allergen.
    The Journal of allergy and clinical immunology, 1998, Volume: 102, Issue:5

    Topics: Adenosine Monophosphate; Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Allergens; Asthma; Bronchoconstriction; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Tolerance; Forced Expiratory Volume; Humans; Methacholine Chloride; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Terbutaline; Time Factors

1998

Trials

11 trial(s) available for adenosine monophosphate and salmeterol xinafoate

ArticleYear
Bronchoprotection by salmeterol: cell stabilization or functional antagonism? Comparative effects on histamine- and AMP-induced bronchoconstriction.
    The European respiratory journal, 1994, Volume: 7, Issue:11

    Topics: Adenosine Monophosphate; Adult; Albuterol; Asthma; Bronchi; Bronchial Provocation Tests; Bronchoconstriction; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Female; Forced Expiratory Volume; Histamine; Humans; Male; Muscle, Smooth; Salmeterol Xinafoate; Time Factors

1994
Fluticasone propionate, salmeterol xinafoate, and their combination in the treatment of nocturnal asthma.
    American journal of respiratory and critical care medicine, 1997, Volume: 155, Issue:4

    Topics: Adenosine Monophosphate; Administration, Inhalation; Administration, Topical; Adrenergic beta-Agonists; Adult; Albuterol; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstrictor Agents; Circadian Rhythm; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Glucocorticoids; Humans; Male; Methacholine Chloride; Salmeterol Xinafoate

1997
Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
    American journal of respiratory and critical care medicine, 1997, Volume: 156, Issue:3 Pt 1

    Topics: Adenosine Monophosphate; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstrictor Agents; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Forced Expiratory Volume; Humans; Male; Methacholine Chloride; Middle Aged; Salmeterol Xinafoate

1997
Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma.
    American journal of respiratory and critical care medicine, 1997, Volume: 156, Issue:6

    Topics: Adenosine Monophosphate; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Bronchodilator Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Forced Expiratory Volume; Histamine; Humans; Male; Salmeterol Xinafoate

1997
Additive bronchoprotective and bronchodilator effects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids.
    Chest, 2000, Volume: 117, Issue:4

    Topics: Acetates; Adenosine Monophosphate; Administration, Inhalation; Administration, Oral; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Cross-Over Studies; Cyclopropanes; Drug Therapy, Combination; Glucocorticoids; Humans; Leukotriene Antagonists; Quinolines; Respiratory Function Tests; Salmeterol Xinafoate; Single-Blind Method; Sulfides; Treatment Outcome

2000
Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.
    Chest, 2001, Volume: 119, Issue:4

    Topics: Acetates; Adenosine Monophosphate; Administration, Inhalation; Administration, Topical; Adrenergic beta-Agonists; Adult; Albuterol; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Breath Tests; Bronchial Provocation Tests; Bronchodilator Agents; Cross-Over Studies; Cyclopropanes; Eosinophils; Female; Glucocorticoids; Humans; Leukocyte Count; Leukotriene Antagonists; Male; Nitric Oxide; Peak Expiratory Flow Rate; Quinolines; Respiratory Mechanics; Salmeterol Xinafoate; Single-Blind Method; Steroids; Sulfides

2001
Effect of salmeterol on seasonal changes in airway responsiveness and exhaled nitric oxide in pollen-sensitive asthmatic subjects.
    Chest, 2002, Volume: 122, Issue:3

    Topics: Adenosine Monophosphate; Administration, Inhalation; Adolescent; Adult; Airway Resistance; Albuterol; Asthma; Breath Tests; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Nitric Oxide; Rhinitis, Allergic, Seasonal; Salmeterol Xinafoate; Seasons

2002
Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.
    American journal of respiratory and critical care medicine, 2003, May-01, Volume: 167, Issue:9

    Topics: Acetates; Adenosine Monophosphate; Adolescent; Adult; Aged; Albuterol; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Biomarkers; Bronchial Provocation Tests; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Male; Middle Aged; Quinolines; Salmeterol Xinafoate; Severity of Illness Index; Sulfides; Treatment Outcome

2003
Effects of fluticasone plus salmeterol versus twice the dose of fluticasone in asthmatic patients.
    European journal of clinical pharmacology, 2003, Volume: 59, Issue:1

    Topics: Adenosine Monophosphate; Adult; Albuterol; Androstadienes; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Bronchodilator Agents; Cross-Over Studies; Drug Therapy, Combination; Endpoint Determination; Fluticasone; Humans; Respiratory Function Tests; Salmeterol Xinafoate; Single-Blind Method

2003
Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2005, Volume: 95, Issue:3

    Topics: Adenosine Monophosphate; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Adult; Albuterol; Androstadienes; Anti-Allergic Agents; Asthma; Biomarkers; Bronchial Provocation Tests; Drug Therapy, Combination; Eosinophil Cationic Protein; Eosinophils; Female; Fluticasone; Humans; Hypersensitivity, Immediate; Inflammation; Male; Nitric Oxide; Respiratory Function Tests; Salmeterol Xinafoate; Terfenadine; Treatment Outcome

2005
Effects of intranasal salmeterol and fluticasone given alone and in combination in persistent allergic rhinitis.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2012, Volume: 108, Issue:1

    Topics: Adenosine Monophosphate; Administration, Intranasal; Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Androstadienes; Anti-Allergic Agents; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Fluticasone; Fluticasone-Salmeterol Drug Combination; Glucocorticoids; Humans; Male; Rhinitis, Allergic, Perennial; Salmeterol Xinafoate; Treatment Outcome

2012

Other Studies

2 other study(ies) available for adenosine monophosphate and salmeterol xinafoate

ArticleYear
Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury.
    Critical care medicine, 2004, Volume: 32, Issue:7

    Topics: Adenosine Monophosphate; Adrenergic beta-Agonists; Albuterol; Animals; Extravascular Lung Water; Pulmonary Alveoli; Pulmonary Edema; Pulmonary Gas Exchange; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Salmeterol Xinafoate; Stereoisomerism

2004
Characteristics of AZD9708, a novel, selective β2-adrenoceptor agonist with rapid onset and long duration of action.
    Pulmonary pharmacology & therapeutics, 2012, Volume: 25, Issue:4

    Topics: Adenosine Monophosphate; Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Asthma; Benzothiazoles; beta-Alanine; Blood Proteins; Bronchi; Bronchodilator Agents; Ethanolamines; Formoterol Fumarate; Guinea Pigs; Humans; Male; Muscle Relaxation; Protein Binding; Pulmonary Disease, Chronic Obstructive; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Time Factors

2012